Dr Reddy’s launches Rapamune's generic version in the US

Dr Reddy’s Laboratories announced the launch of its Sirolimus tablets, a therapeutic equivalent generic version of Rapamune (Sirolimus) in the US market


(Photo Courtesy: www.nordiclifescience.org)

The generic drug has received approval nod from the United States Food and Drug Administration (USFDA).

The Rapamune tablets brand had US sales of approximately $206 million MAT for the most recent twelve months ending in August 2014, according to IMS Health.

Dr Reddy's Sirolimus tablets are available in 1mg and 2mg in bottle counts of 100.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email